ULBI - Ultralife - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ULBI is currently covered by 1 analysts with an average price target of $14.21. This is a potential upside of $7.2 (102.71%) from yesterday's end of day stock price of $7.01.

Ultralife's activity chart (see below) currently has 5 price targets and 5 ratings on display. The stock rating distribution of ULBI is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40% with an average time for these price targets to be met of 701 days.

Highest price target for ULBI is $14, Lowest price target is $14, average price target is $14.

Most recent stock forecast was given by JOSH SULLIVAN from BENCHMARK on 28-May-2025. First documented stock forecast 26-Mar-2021.

Best performing analysts who are covering ULBI - Ultralife:

Josh Sullivan

Currently out of the existing stock ratings of ULBI, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 26-Mar-2021

$14

$7.45 (113.74%)

$14

9 months 17 days ago
(28-May-2025)

2/5 (40%)

$7.2 (105.88%)

701

Show more analysts

Please expand the browser size to see the chart

What is ULBI (Ultralife) average time for price targets to be met?

On average it took 701 days on average for the stock forecasts to be realized with a an average price target met ratio 40

Which analyst has the current highest performing score on ULBI (Ultralife) with a proven track record?

JOSH SULLIVAN

Which analyst has the most public recommendations on ULBI (Ultralife)?

Josh Sullivan works at JONESTRADING and has 7 price targets and 7 ratings on ULBI

Which analyst is the currently most bullish on ULBI (Ultralife)?

Josh Sullivan with highest potential upside - $7.45

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?